𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Erlotinib in the first-line treatment of non-small-cell lung cancer

✍ Scribed by D’Arcangelo, Manolo ;Cappuzzo, Federico

Book ID
120336849
Publisher
Expert Reviews
Year
2013
Tongue
English
Weight
1009 KB
Volume
13
Category
Article
ISSN
1473-7140

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An International, Multicenter, Randomize
An International, Multicenter, Randomized Phase III Study of First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Versus First-Line Cisplatin/Gemcitabine Followed by Second-Line Erlotinib in Advanced Non–Small-Cell Lung Cancer: Treatment Rationale and Protocol Dynamics of the TORCH Trial
✍ Cesare Gridelli; Charles Butts; Fortunato Ciardiello; Ronald Feld; Ciro Gallo; F 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 91 KB